Downregulation of immunomodulator gene expression in LPS-stimulated human polymorphonuclear leukocytes by the proton pump inhibitor lansoprazole

Journal of Infection and Chemotherapy

Volumn 15, Issue 6, 2009, Pages 374-379

  Ubagai, Tsuneyuki ^a   Koshibu, Yoji ^a   Koshio, Osamu ^a   Nakaki, Toshio ^a   Ono, Yasuo ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Lansoprazole; Lipopolysaccharide; Polymorphonuclear leukocyte; RT PCR; Tumor necrosis factor

Indexed keywords

BETA ACTIN; CD11B ANTIGEN; CD14 ANTIGEN; CD18 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; LANSOPRAZOLE; LIPOPOLYSACCHARIDE; MESSENGER RNA; OMEPRAZOLE; PROTON PUMP INHIBITOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NUCLEOTIDE SEQUENCE;

EID: 76749141388     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-009-0728-2     Document Type: Article

References (26)

1. M. Aihara D. Tsuchimoto H. Takizawa A. Azuma H. Wakebe Y. Ohmoto, et al. 1997 Mechanisms involved in Helicobacter pyloriinduced interleukin-8 production by a gastric cancer cell line, MKN45 Infect Immun 65 3218 3224 1:CAS:528:DyaK2sXkvVakurw%3D 9234778
2. A. Masamune T. Shimosegawa O. Masamune N. Mukaida M. Koizumi T. Toyota 1999 Helicobacter pylori-dependent ceramide production may mediate increased interleukin 8 expression in human gastric cancer cell lines Gastroenterology 116 1330 1341 10.1016/S0016-5085(99)70497-X 1:CAS:528:DyaK1MXjvFOlu7Y%3D 10348816 (Pubitemid 29258881)
3. S.A. Sharma M.K.R. Tummuru M.J. Blaser L.D. Kerr 1998 Activation of IL8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-κB in gastric epithelial cells J Immunol 1 160 2401 2407 1:CAS:528:DyaK1cXhtlCitrY%3D
4. M. Baggiolini B. Dewald B. Moser 1994 Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines Adv Immunol 55 97 179 10.1016/S0065-2776(08)60509-X 1:CAS:528:DyaK2cXktlamtr8%3D 8304236
5. T. Ando K. Kusugami M. Ohsuga M. Shinoda M. Sakakibara H. Saito, et al. 1996 Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis Am J Gastroenterol 91 1150 1156 1:STN:280:DyaK283jslKhuw%3D%3D 8651162
6. T. Shimoyama S.M. Everett M.F. Dixon A.T.R. Axon J.E. Crabtree 1998 Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cag A positivity and severity of gastritis J Clin Pathol 51 765 770 10.1136/jcp.51.10.765 1:STN:280:DyaK1M7kslChsw%3D%3D 10023340
7. N. Uemura Y. Oomoto T. Mukai S. Okamoto S. Yamaguchi H. Mashiba, et al. 1997 Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients Aliment Pharmacol Ther 11 793 800 10.1046/j.1365-2036.1997.00218. x 1:CAS:528:DyaK2sXmtl2hurk%3D 9305491
8. +) ATPase Nature 290 159 161 10.1038/290159a0 1:CAS:528:DyaL3MXksFCksbo%3D 6259537 (Pubitemid 11149696)
9. S. Shi U. Klotz 2008 Proton pump inhibitors: an update of their clinical use and pharmacokinetics Eur J Clin Pharmacol 64 935 951 10.1007/s00228-008- 0538-y 1:CAS:528:DC%2BD1cXht1Sqs7jN 18679668
10. Y. Naito T. Yoshikawa 2005 Carcinogenesis and chemoprevention in gastric cancer associated with Helicobacter pylori infection: role of oxidants and antioxidants J Clin Biochem Nutr 36 37 49 10.3164/jcbn.36.37 1:CAS:528:DC%2BD2MXps1Knsbo%3D (Pubitemid 41195789)
11. -245 Gut 33 617 621 10.1136/gut.33.5.617 1:CAS:528:DyaK38XltVequr8%3D 1319381
12. N. Yoshida T. Yoshikawa Y. Tanaka N. Fujita K. Kassai Y. Naito, et al. 2000 A new mechanism for anti-inflammatory actions of proton pump inhibitors - inhibitory effects on neutrophil-endothelial cell interactions Aliment Pharmacol Ther 14 Suppl1 74 81 10.1046/j.1365-2036.2000.014s1074.x 1:CAS:528: DC%2BD3cXjtl2js7s%3D 10807407
13. U. Bicakci B. Tander E. Ariturk B.K. Aydin O. Aydin R. Rizalar, et al. 2005 Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/reoxygenation induced intestinal injury in newborn rats Pediatr Surg Int 21 800 805 10.1007/s00383-005-1538-y 16205929 (Pubitemid 41504118)
14. M. Suzuki M. Nakamura M. Mori S. Miura M. Tsuchiya H. Ishii 1995 Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori J Clin Gastroenterol 20 Suppl2 S93 S96 7594353
15. M. Suzuki M. Mori S. Miura M. Suematsu D. Fukuda H. Kimura, et al. 1996 Omeprazole attenuates oxygen-derived free radical production from human neutrophils Free Radic Biol Med 21 727 731 10.1016/0891-5849(96)00180-3 1:CAS:528:DyaK28Xmt12ltrc%3D 8891677 (Pubitemid 26331104)
16. P. Maity S. Bindu V. Choubey A. Alam K. Mitra M. Goyal, et al. 2008 Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal J Biol Chem 283 14391 14401 10.1074/jbc.M800414200 1:CAS:528: DC%2BD1cXlvFyjs78%3D 18375387
17. F. Baert M. Noman S. Vermeire G.V. Assche G.D.'. Haens A. Carbonez, et al. 2003 Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease N Engl J Med 348 601 608 10.1056/NEJMoa020888 1:CAS:528:DC%2BD3sXhtVyqtL0%3D 12584368 (Pubitemid 36204954)
18. H. Ito M. Takazoe Y. Fukuda T. Hibi K. Kusugami A. Andoh, et al. 2004 2004. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease Gastroenterology 126 989 996 10.1053/j.gastro.2004.01.012 1:CAS:528:DC%2BD2cXkt1Krsbo%3D 15057738 (Pubitemid 38451170)
19. H. Ito 2005 Treatment of Crohn's disease with anti-IL-6 receptor antibody J Gastroenterol 40 32 34 10.1007/BF02990576 1:CAS:528:DC%2BD2MXjtFWjt7g%3D 15902961
20. T. Ubagai S. Tansho T. Ito Y. Ono 2008 Influences of aflatoxin B1 on reactive oxygen species generation and chemotaxis of human polymorphonuclear leukocytes Toxicol in Vitro 22 1115 1120 10.1016/j.tiv.2008.01.007 1:CAS:528:DC%2BD1cXkvFWgsL8%3D 18316174
21. N. Watanabe T. Shimada Y. Ohtsuka H. Hiraishi T. Terano 1997 Proinflammatory cytokines and Helicobacter pylori stimulate CC-chemokine expression in gastric epithelial cells J Physiol Pharmacol 48 405 413 1:CAS:528:DyaK2sXmslOnur4%3D 9376623
22. E. Capodicasa F. Bellis M.A. Pelli 1999 Effect of lansoprazole on human leukocyte function Immunopharmacol Immunotoxicol 21 357 377 10.3109/ 08923979909052768 1:CAS:528:DyaK1MXjtlamt7o%3D 10319286
23. I. Aoki M. Okumura T. Yashiki 1991 High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine J Chromatogr 571 283 290 10.1016/0378-4347(91)80457-N 1:CAS:528:DyaK38XltVOhtw%3D%3D 1810958
24. M. Nakamura M. Asada K. Atsuda H. Matsui T. Watanabe K. Higuchi, et al. 2005 Lansoprazole binding to the neutrophils in dextran sulfate sodium-induced rat colitis Inflammopharmacology 13 303 315 10.1163/156856005774423980 1:CAS:528:DC%2BD2MXht12itrvE 16259749 (Pubitemid 41607390)
25. L.A. Noach N.B. Bosma J. Jansen F.J. Hoek S.J.H. van Deventer G.N.J. Tytgat 1994 Mucosal tumor necrosis factor-á, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection Scand J Gastroenterol 1 29 425 429 10.3109/00365529409096833 1:CAS:528: DyaK2cXkvVSlurg%3D
26. J.L. Wallace 1991 Possible mechanisms and mediators of gastritis associated with Helicobacter pylori infection Scand J Gastroenterol 26 65 670 10.3109/00365529109098226